Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing

被引:16
作者
Hovhannisyan, RH
Warzecha, CC
Carstens, RP
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA
关键词
D O I
10.1093/nar/gkj407
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing of fibroblast growth factor receptor-2 (FGFR2) mutually exclusive exons IIIb and IIIc results in highly cell-type-specific expression of functionally distinct receptors, FGFR2-IIIb and FGFR2-IIIc. We previously identified an RNA cis-element, ISE/ISS-3, that enhanced exon IIIb splicing and silenced exon IIIc splicing. Here, we have performed comprehensive mutational analysis to define critical sequence motifs within this element that independently either enhance splicing of upstream exons or repress splicing of downstream exons. Such analysis included use of a novel fluorescence-based splicing reporter assay that allowed quantitative determination of relative functional activity of ISE/ISS-3 mutants using flow cytometric analysis of live cells. We determined that specific sequences within this element that mediate splicing enhancement also mediate splicing repression, depending on their position relative to a regulated exon. Thus, factors that bind the element are likely to be coordinately involved in mediating both aspects of splicing regulation. Exon IIIc silencing is dependent upon a suboptimal branchpoint sequence containing a guanine branchpoint nucleotide. Previous studies of exon IIIc splicing in HeLa nuclear extracts demonstrated that this guanine branchsite primarily impaired the second step of splicing suggesting that ISE/ISS-3 may block exon IIIc inclusion at this step. However, results presented here that include use of newly developed in vitro splicing assays of FGFR2 using extracts from a cell line expressing FGFR2-IIIb strongly suggest that cell-type-specific silencing of exon IIIc occurs at or prior to the first step of splicing.
引用
收藏
页码:373 / 385
页数:13
相关论文
共 41 条
[1]   Bimolecular exon ligation by the human spliceosome [J].
Anderson, K ;
Moore, MJ .
SCIENCE, 1997, 276 (5319) :1712-1716
[2]   A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements [J].
Baraniak, AP ;
Lasda, EL ;
Wagner, EJ ;
Garcia-Blanco, MA .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :9327-9337
[3]   PROTEIN-COMPONENTS SPECIFICALLY ASSOCIATED WITH PRESPLICEOSOME AND SPLICEOSOME COMPLEXES [J].
BENNETT, M ;
MICHAUD, S ;
KINGSTON, J ;
REED, R .
GENES & DEVELOPMENT, 1992, 6 (10) :1986-2000
[4]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[5]   Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization [J].
Blanchette, M ;
Chabot, B .
EMBO JOURNAL, 1999, 18 (07) :1939-1952
[6]   Functional crosstalk between exon enhancers, polypyrimidine tracts and branchpoint sequences [J].
Buvoli, M ;
Mayer, SA ;
Patton, JG .
EMBO JOURNAL, 1997, 16 (23) :7174-7183
[7]   Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer [J].
Carstens, RP ;
Eaton, JV ;
Krigman, HR ;
Walther, PJ ;
Garcia-Blanco, MA .
ONCOGENE, 1997, 15 (25) :3059-3065
[8]   An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing [J].
Carstens, RP ;
McKeehan, WL ;
Garcia-Blanco, MA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2205-2217
[9]   An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein [J].
Carstens, RP ;
Wagner, EJ ;
Garcia-Blanco, MA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) :7388-7400
[10]   Functional analysis of the polypyrimidine tract in pre-mRNA splicing [J].
Coolidge, CJ ;
Seely, RJ ;
Patton, JG .
NUCLEIC ACIDS RESEARCH, 1997, 25 (04) :888-895